Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
West Afr J Med ; 39(4): 369-374, 2022 Apr 29.
Article in English | MEDLINE | ID: mdl-35489037

ABSTRACT

BACKGROUND: Globally, peripartum or puerperal infections account for about one tenth of maternal mortality, most of which occur in low income countries. Therefore, vaginal preparation with an antiseptic prior to a caesarean delivery could be considered an additional measure to prevent subsequent infectious morbidities. OBJECTIVES: To evaluate vaginal preparation with 0.3% chlorhexidine solution in the prevention of endometritis, surgical site infection and post-operative fever following emergency caesarean section. METHODS: This prospective randomized controlled trial (RCT) was conducted among 240 participants planned for emergency caesarean sections (CS) at term in the University of Medical Sciences Teaching Hospital Complex, Ondo State, Nigeria. Participants were randomised into either group "A" (study) or "B" (control). The former had vaginal preparation with 0.3% chlorhexidine gluconate immediately after anaesthesia while the latter received normal saline. Participants were followed up post-operatively during which clinical features of puerperal infectious morbidities were observed for each during admission as well as 8th and 14th days after delivery. RESULTS: The rate and risk of endometritis were significantly lower in the study group compared to the control; 5.0% versus 13.3%, respectively (chi squared =5.004; p=0.042, RR = 0.38; 95% CI = 0.15-0.94; p = 0.042; RRR = 0.62). Post-operative fever and surgical site infection, were also lower in the study group compared to the controls, but the difference was not statistically significant. CONCLUSION: When compared to placebo, pre-caesarean section vaginal preparation with 0.3% chlorhexidine solution significantly reduced only the rate and risk of post-operative endometritis among infectious morbidities.


CONTEXTE: À l'échelle mondiale, infections péripartum ou puerpérales représentent environ un dixième de la mortalité maternelle, dont la plupart se produisent dans les pays à faible revenu. Par conséquent, la préparation vaginale avec un antiseptique avant un accouchement par césarienne pourrait être considéré comme un mesure supplémentaire pour prévenir les morbidités infectieuses subséquentes. OBJECTIFS: Évaluer la préparation vaginale avec 0.3%solution de chlorhexidine dans la prévention de l'endométrite, site chirurgical infection et fièvre postopératoire après une césarienne d'urgence section. MÉTHODES: Cet essai prospectif randomisé contrôlé (ECR)a été menée auprès de 240 participants prévus pour une urgence césariennes (CS) à terme à l'Université des sciences médicales Complexe hospitalier universitaire, État d'Ondo, Nigéria. Les participants étaient randomisé dans le groupe "A" (étude) ou "B" (témoin). Celui-là avait une préparation vaginale avec 0.3 % de gluconate de chlorhexidine immédiatement après l'anesthésie alors que ce dernier a reçu une solution saline normale. Les participants ont été suivis postopératoirement au cours desquels des caractéristiques de morbidité infectieuse puerpérale ont été observées pour chaquelors de l'admission ainsi que les 8ème et 14ème jours après la livraison. RÉSULTATS: Le taux et le risque d'endométrite étaient significativement plus faibles dans le groupe d'étude par rapport au groupe témoin; 5.0 % contre 13.3 %, respectivement (chi carré =5.004; p=0.042, RR = 0.38; 95% CI = 0.15­0.94; p = 0.042; RRR = 0.62). Fièvre postopératoire et infection du site chirurgical, étaient également plus faibles dans le groupe d'étude par rapport aux témoins, mais lela différence n'était pas statistiquement significative. CONCLUSION: Par rapport au placebo, pré-césarienne préparation vaginale avec une solution de chlorhexidine à 0.3% significativement réduit uniquement le taux et le risque d'endométrite postopératoire chez morbidités infectieuses. Mots-clés: Chlorhexidine, Préparation Vaginale, Infection Puerpéral emorbidité, Césarienne, Endométrite, Fièvre Postopératoire, Infection Du Site Chirurgical.


Subject(s)
Endometritis , Puerperal Infection , Administration, Intravaginal , Cesarean Section/adverse effects , Chlorhexidine , Endometritis/epidemiology , Endometritis/prevention & control , Female , Humans , Morbidity , Povidone-Iodine , Pregnancy , Puerperal Infection/epidemiology , Puerperal Infection/prevention & control , Surgical Wound Infection/epidemiology , Surgical Wound Infection/prevention & control
2.
Niger Postgrad Med J ; 20(4): 336-40, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24633279

ABSTRACT

AIMS AND OBJECTIVES: Intrauterine contraceptive device is a highly acceptable method of contraception, however despite it sacceptability many users still discontinue its use for various reasons, this study was embarked upon to determine the rate of its discontinuation and the factors associated with its discontinuation. MATERIALS AND METHODS: It was a retrospective study of 10 years duration starting from January 1997 to December 2006 at the University College Hospital, Ibadan. A total of 6,515 had insertion of IUCD (Copper T380 A) over the study period and 1,295(19.9%) discontinued within the period with the highest discontinuation rate being the first year while the least discontinuation rate was the 9th year. RESULTS: The commonest reason for discontinuation was the desire for pregnancy which accounted for 665(51.4%) of removal followed by menopause in 225(17.4%), no reason was found in 204(15.7%), side effects accounted for 101(7.8%) of removal, husbands wish 53(4.1%) and changing to another method accounted for 47(3.6%) of removal. The reasons for discontinuation were significantly associated with the clients age, side effects, number of living children and their educational status. CONCLUSION: The rate of discontinuation is still high especially because of the desire to get pregnant while some even discontinued for no reason. It therefore becomes imperative for providers of family planning to further enlighten the populace on the benefit of limiting their family size and to also encourage the prolonged use of the device in those who discontinue for no reason by improving on our counseling methods.


Subject(s)
Device Removal/psychology , Intrauterine Devices, Copper , Patient Acceptance of Health Care/psychology , Adolescent , Adult , Age Factors , Device Removal/statistics & numerical data , Educational Status , Family Characteristics , Female , Hospitals, University , Humans , Middle Aged , Nigeria , Parity , Patient Acceptance of Health Care/statistics & numerical data , Retrospective Studies , Time Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...